PSMC3IP and neoplasm: When patients were divided into two groups by GT198 expression scores, higher level of GT198 expression was significantly associated with decreased progression-free survival in patients (HR = 6.127, 95% CI) (Figure 3M), suggesting that the presence of GT198+ pericytes promotes tumor progression and is a worse prognostic indicator in oral cancer patients.